SURENAC
DEAD

Serial Number

86211937

Owner

Tiara Pharmaceuticals

Filing Date

Mar 5, 2014

Add to watchlist:

No watchlists yet
View on USPTO

SURENAC Trademark

Serial Number: 86211937

SURENAC is a trademark filed by Tiara Pharmaceuticals on March 5, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Tiara Pharmaceuticals (2 trademarks)

4546 B10 El camino Real #304
Los Altos, CA 94022

Entity Type: 03

Trademark Details

Filing Date

March 5, 2014

Registration Date

Not Registered

Published for Opposition

August 5, 2014

Goods & Services

Anti-diabetic pharmaceuticals; Capsules sold empty for pharmaceuticals; Cardiovascular pharmaceuticals; Digestives for pharmaceutical purposes; Drug delivery agents in the form of a coating for sustained release formulations that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Gelatin capsules sold empty for pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention of inflammation, cardiovascular disease (CVD), multiple sclerosis (MS), and pulmonary diseases, including chronic obstructive pulmonary disease (COPD); Pharmaceutical preparations for the treatment and prevention of diabetes, renal disease, colitis; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, antidepressants; the foregoing goods containing N-acetylcysteine

Active chemical ingredients for use in the manufacture of pharmaceuticals for treating inflammation; Excipients for use in the manufacture of pharmaceuticals; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Preservatives for pharmaceutical preparations; the foregoing goods containing N-acetylcysteine

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Sep 8, 2015 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 7, 2015 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 3, 2015 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Dec 19, 2014 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 21, 2014 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 5, 2014 NPUB
PUBLISHED FOR OPPOSITION
Aug 5, 2014 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 16, 2014 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 1, 2014 PREV
ASSIGNED TO LIE
Jun 30, 2014 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 12, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 12, 2014 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 12, 2014 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 12, 2014 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 12, 2014 CNEA
ASSIGNED TO EXAMINER
Jun 10, 2014 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Mar 19, 2014 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2014 NWOS
NEW APPLICATION ENTERED
Mar 8, 2014 NWAP